New: Good Practice Guide for Prescribers of CBPMs
June 14, 2024 | IN INFORMATION | BY Kate Thorpe
Since the legalisation of cannabis-based medicinal products (CBPMs) in the UK in November 2018, around 40,000 patients have received these treatments, with numbers steadily increasing. There are currently 40 clinics and about 140 prescribers operating within the private sector.
However, the adoption of these medicines within the NHS has been slow, and there are no compulsory training requirements for prescribers. This has led to significant variations in clinical practice.
To address these challenges, the Medical Cannabis Clinicians Society (MCCS) has developed a Good Practice Guide. This guide aims to support prescribers and ensure patients can safely access these valuable medicines. While it is tailored primarily for clinics that focus on prescribing cannabis, the fundamental principles are relevant to a broader range of medical settings.
The MCCS hopes this guide will be adopted widely, pleading to practices that benefit patients and improve the overall quality of the medical cannabis industry. This effort highlights our dedication to raising standards and supporting prescribers with practical, applicable guidelines and support.
Download the Good Practice Guide >>>
You can access all our public publications – including this recently published Good Practice Guide – on our website.
Not yet a member? Join the Society.